申请人:SELEXAGEN THERAPEUTICS INC
公开号:WO2011085269A1
公开(公告)日:2011-07-14
Described herein are compounds, pharmaceutical compositions and methods for the inhibition of RAF kinae mediated signaling. Said compounds, pharmaceutical compositions and methods have utility in the treatment of human disease and disorders.
本文描述了用于抑制RAF激酶介导信号的化合物、药物组合物和方法。这些化合物、药物组合物和方法在治疗人类疾病和疾病方面具有实用性。